Here we found that deficiency of the YBX3 could remarkably inhibit the activation of PI3K/AKT signaling, suppress EMT and MMP1 by increasing E-cadherin expression and decreasing Vimentin and MMP1 level in NPC cell lines. The gene discussed is YBX3; the disease is nasopharyngeal carcinoma.